The Swedish Organized Service Screening Evaluation Group. Duffy SW, Tabar L, Tony H.H. Chen et al.
Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data.
Cancer Epidemiol Biomarkers Prev 2006;15(1):45-51.
Swedish Organized Service Screening Evaluation Group. Duffy SW, Tabar L, Tony H.H. Chen et al.
Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 2. Validation with new analytic methods.
Cancer Epidemiol Biomarkers Prev 2006;15:52-6.
Duffy SW, Tabar L, Vitak B, Warwick J.
Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?
Breast J. 2006 Jan-Feb;12 Suppl 1:S91-5.
Tabar L, Tony Hsiu-His Chen, Amy Min-Fang Yen, Peter Dean.
Detection, Diagnosis and Treatment of Early Breast Cancer Requires Creative Interdisciplinary Teamwork.
Semin Breast Dis 8:4-9, 2005.
Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Bjorneld L, Myles JP, Warwick J.
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.
Duffy SW, Smith RA, Tabar L.
Re: Efficacy of breast cancer screening in the community according to risk level.
J Natl Cancer Inst. 2005 Nov 16;97(22):1703; author reply 1703-4.
Duffy SW, Smith RA, Gabe R, Tabar L, Yen AM, Chen TH.
Screening for breast cancer.
Surg Oncol Clin N Am. 2005 Oct;14(4):671-97.
Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA.
Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
Cancer. 2004 Oct 15;101(8):1745-59.
Smith RA, Duffy SW, Tabar L, Gabe R.
Screening and early detection. In: Singletary SE, Robb GL, Hortobagyi GN, editors. Advanced Therapy of Breast Disease. Hamilton (Ontario): BC Decker Inc.; 2004.p.202-12.
Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH.
The randomized trials of breast cancer screening: what have we learned?
Radiol Clin North Am. 2004 Sep;42(5):793-806.
Tabar L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW.
Number needed to screen: lives saved over 20 years of follow-up in mammographic screening.
J Med Screen. 2004;11(3):126-9.
Tabar L, Lebovic GS, Hermann GD, Kaufman CS, Alexander C, Sayre J.Clinical assessment of a radiolucent cushion for mammography.
Acta Radiol. 2004 Apr;45(2):154-8
Warwick J, Tabar L, Vitak B, Duffy SW:
Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study
Cancer. 2004 Apr 1;100(7):1331-6 .
Duffy SW, Tabar L, Vitak B, Day NE, Smith R, Chen HH, Yen MF:
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.
Eur J Cancer. 2003 Aug;39(12):1755-60.
Yen MF, Tabar L, Vitak B, Smith RA, Chen HH, Duffy SW:
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ In breast cancer screening.
Eur J Cancer. 2003 Aug;39(12):1746-54
Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH:
The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
Ann Oncol. 2003 Aug;14(8):1196-8.
Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW:
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
Lancet. 2003 Apr 26;361(9367):1405-10.
Myles JP, Nixon MR, Duffy SW, Tabar L, Boggis C, Evans G, Shenton A, Howell A:
Bayesian evaluation of breast cancer screening using data from two studies.
Stat Med. 2003 May 30;22(10):1661-74
Tabar L, Dean PB:
Mammography and breast cancer: the new era.
Int J Gynaecol Obstet. 2003 Sep;82(3):319-26. Review.
Tabar L, Smith RA, Vitak B, Yen MF, Chen HH, Warwick J, Myles JP, Duffy SW:
Mammographic screening: a key factor in the control of breast cancer.
Cancer J. 2003 Jan-Feb;9(1):15-27. Review.
Tabar L, :
Mammographic Screening :Key Conclusions Supporting Screening
Breast Journal. 2003 January/February; 9(Supplement):S7-S10
Duffy SW, Cuzick J, Tabár L, Vitak V, Chen HH, Yen MF, Smith RA:
Correcting for non-compliance bias in case-control studies to evaluate cancer screening programs.
App.Stat. 2002, 51,235-243
Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg L:
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Cancer. 2002 Aug 1;95(3):458-69
Tabar L, Duffy SW, Yen MF, Warwick J, Vitak B, Chen HH, Smith RA:
All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
J Med Screen. 2002;9(4):159-62
Duffy SW, Tabar L, Smith RA:
The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche.
J Surg Oncol. 2002 Dec;81(4):159-62; discussion 162-6
Duffy SW, L Tabár, Smith RA:
The Mammographic Screening Trials: Commentary on the Recent Work by Olsen and Gotzsche.
CA Cancer J Clin, Vol 52, No 2, March/April 2002: pp 68-71
Tabar L, Smith RA, Duffy SW:
Update on effects of screening mammography.
L ancet. 2002 Jul 27;360(9329):337; author reply 339-40.
Gram IT, Funkhouser E, Nordgard L, Tabar L, Ursin G:
Oral contraceptive use and mammographic patterns.
Eur J Cancer Prev. 2002 Jun;11(3):265-70.
Tabár L, Duffy SW, Smith RA:
Author Reply
Cancer, Vol 94, January 15, 2002: pp581-583
Heywang-Kobrunner SH, Bick U, Bradley WG Jr, Bone B, Casselman J, Coulthard A, Fischer U, Muller-Schimpfle M, Oellinger H, Patt R, Teubner J, Friedrich M, Newstead G, Holland R, Schauer A, Sickles EA, Tabar L, Waisman J, Wernecke KD:
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions.
Eur Radiol. 2001;11(4):531-46.
Duffy SW, Tabar L, Smith RA:
Screening for breast cancer with mammography.
Lancet. 2001 Dec 22-29;358(9299):2166; author reply 2167-8.
Silverstein M J et al:
Special report; international consensus conference. Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment.
Journal of the American College of Surgeons, Vol 193, No 3, September 2001: pp 297-302
Kaufman CS, Jacobson-Kaufman L, Thorndike-Christ T, Kaufman L, Tabar L:
A treatment scale for axillary management in breast cancer.
Am J Surg. 2001 Oct;182(4):377-83
Grogan M, Tabar L, Chua B, Chen HH, Boyages J:
Estimating the benefits of adjuvant systemic therapy for women with early breast cancer.
Br J Surg. 2001 Nov;88(11):1513-8
Warren Burhenne LJ, Smith RA, Tabar L, Dean PB, Perry N, Sickles EA:
Mammographic screening: international perspective.
Semin Roentgenol. 2001 Jul;36(3):187-94. Review
Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA:
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Cancer. 2001 May 1;91(9):1724-31
Nixon RM, Pharoah P, Tabár L, Krusemo UB, Duffy SW, Prevost TC, Chen HH:
Mammographic Screening in Women a Family History of Breast Cancer: Some Results From the Swedish Two-County Trial.
Rev. Epidém. Et Santé Publ, No 48, 2000: pp 325-331
Tabar L, Vitak B, Chen HH, et al.
The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 200;38:625-51.
Tabar L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA:
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study.
Lancet. 2000 Feb 5;355(9202):429-33. Erratum in: Lancet 2000 Apr 15;355(9212):1372.
Nixon RM, Prevost TC, Duffy SW, Tabár L, Vitak B, Chen HH:
Some Random-Effects Models for the Analysis of Matched-Cluster Randomised Trials: Application to the Swedish Two-County Trial of Breast-cancer Screening.
Journal of Epidemiology an d Biostatics, Vol 5, No 6 2000: pp 349-358
Tot T, Tabár L, Dean PB:
The Pressing Need for Better Histologic-Mammographic Correlation of the Many Variations in Normal Breast Anatomy.
Virchows Arch 2000, 437: pp 338-344
Warren Burhenne LJ, Wood SA, D'Orsi CJ, Feig SA, Kopans DB,
O'Shaughnessy KF, Sickles EA, Tabar L, Vyborny CJ, Castellino RA:
Potential contribution of computer-aided detection to the sensitivity of screening mammography.
Radiology. 2000 May;215(2):554-62. Erratum in: Radiology 2000 Jul;216(1):306.
Tabár L et al:
Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment.
Journal of the American College of Surgeons, Vol 193, No 3, September 2000: pp 297-302
Tabár L, Duffy SW, Dean PB:
Authors´reply
The Lancet, Vol 355, April 29 2000: pp 1552-155
Tabár L, Dean PB, Kaufman KS , Duffy SW, Chen HH:
A New Era in the Diagnosis of Breast Cancer.
Surgical Oncology Clinics of North America , Vol 9, no 2 April 2000: pp233-277
Chen HH, Kuo HS, Yen MF, Lai MS, Tabár L, Duffy SW:
Estimation of Sojourn Time in Chronic Disease, Screening Without Data on Interval Cases.
Biometrics, Vol 56, No 1 March 2000: pp 167-172
Tabar L, Duffy SW:
Author reply
Cancer. 2000 Apr 1;88(7):1759
Tabar L, Chen HH, Duffy SW, Krusemo UB:
Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening.
Jpn J Clin Oncol. 1999 Dec;29(12):608-16.
Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabár L et al:
10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage 1 Breast Cancer: A Randomized Trial.
Journal of Clinical Oncology, Vol 17, No 8 (August), 1999: pp 2326-2333
Tabár L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA:
A Novel Method for Prediction of Long-term Outcome of Women with T1a, T1b and 10-14 mm Invasive Breast Cancers: a prospective study.
Lancet, Vol 355, Feb 5, 2000, pp 429-433.
Tabár L, Duffy SW:
Criticism of Swedish Mammography Trials Were Wrong.
BMJ, Vol 19, 20 November 1999. pp1367
Duffy SW, Tabar L:
Screening mammography re-evaluated.
Lancet. 2000 Feb 26;355(9205):747-8; author reply 752
Tabar L.
Mammography saves life through early intervention in the natural course of breast cancer.
Lakartidningen. 1999 Apr 21;96(16):1943. Swedish
Tabar L.
Assessment of the effect of mammographic screening can not be based on wrong data
Lakartidningen. 1999 Apr 7;96(14):1763-4. Swedish.
Tabár L, Vitak B, Chen HH, Prevost TC, Duffy SW:
Update of the Swedish Two-County Trial of breast Cancer Screening: histologic grade- specific and age-specific results.
Swiss Surg 1999;5:199-204
Duffy SW, Tabár L, Smith RA, Krusemo UB, Prevost TC, Chen HH:
Risk of Breast Cancer and Risks with Breast Cancer: the relationship between histological type and conventional risk factors, disease progression, and survival.
Seminars in Breast Disease, Vol 2, No. 4, December 1999, pp 292-300.
Tabár L, Duffy SW, Vitak B, Chen HH, Prevost:
The Natural History of Breast Carcinoma: What have we learned from screening?
Cancer 1999; Vol 86, Number 3, pp 449-462.
Tabár L, Chen HH, Duffy SW, Krusemo UB:
Primary and Adjuvant Therapy, Prognostic Factors and Survival in 1053 Breast Cancers Diagnosed in a Trial of Mammography Screening.
Jpn J Clin Oncol 1999; 29(12)608-616.
Gram IT, Funkhouser E, L Tabár:
Moderate Physical Activity in Relation to Mammographic Patterns.
Cancer Epidemiology, Biomarkers & Prevention 1999;Vol 8, pp 117-122.47
Chen HH, Thurfjell E, Duffy SW, L Tabár:
Evaluation by Markov chain models of a non-randomised breast cancer Screening programme in women aged under 50 years in Sweden .
J Epidemiol Community Health 1998;52:39-335.
Gram IT, E Funkhouser and L Tabár:
Anthropometric indices in relation to mammographic patterns among perimenopausal women.
Int J of Cancer. 1997;73:323-326
Duffy SW, Day NE, Tabár L, Chen HH, Smith RA:
Markov Models of Breast Tumor Progression: Some Age-specific Results.
Journal of the National Cancer Institute Monographs. 1997;No 22, 93-97 .
Larsson LG, Andersson I, Bjurstam N, Fagerberg G, Frisell F, Tabár L, Nyström L:
Updated Overview of the Swedish Randomized Trials on Breast Cancer Screening With Mammography: Age Group 40 - 49 at Randomization.
Journal of the National Cancer Institute Monographs. 1997;No. 22, 57 - 61.
Tabár L, Chen HH , Fagerberg G, Duffy SW , Smith RA:
Recent results from the Swedish Two-County Trial: the effect of age, histologic type and mode of detection on the efficacy of Breast cancer screening.
Journal of the National Cancer Institute Monographs. 1997;No 22, 43-49.
Chen HH, Duffy SW, Tabár L:
A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer.
Journal of Applied Statistics, 1997, 24:(3), 265-278.
Liljegren G, A Lindgren, J Bergh, H Nordgren, L Tabár,L Holmberg:
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy.
Annals of Oncology 1997;8:235-241.
Smart C R, Mettlin CP, Tabár L, Eyre HJ:
Cancer Screening and Early Detection. pp 511-530.
In: Cancer Medicine, 4th Edition. Ed. Holland J, Bast RC, Morton DL, Frei E, Kufe DW, Weichelbaum RR. Williams & Wilkins, 1997.
Tabár L, Gad A, Parsons W, Neeland DB:
Mammographic Appearances of in Situ Carcinomas.
In: Ductal Carcinoma in Situ of the Breast pp 95 - 117 ED.: Siverstein, MJ. Williams & Wilkins. 1997.
Chen HH, Duffy SW, Tabár L, Day NE:
Markov chain models for progression of breast cancer. Part II: prediction of outcomes for different screening regimes.
J. Epid and Biostatistics, 1997;2:(1), 25-35.
Chen HH, Duffy SW, Tabár L, Day NE:
Markov chain models for progression of breast cancer, Part I: tumour attributes and the preclinical screen-detectable phase.
J. Epid and Biostatistics 1997;2:(1), 9-23.
Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabar L, Holmberg L.
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy.
Ann Oncol. 1997 Mar;8(3):235-41.
Gram IT, Funkhouser E, Tabar L.
Anthropometric indices in relation to mammographic patterns among peri-menopausal women.
Int J Cancer. 1997 Nov 4;73(3):323-6.
Gram IT, E Funkhouser , L Tabár:
The Tabár classification of mammographic parenchymal patterns.
Eur J. Radiology 1997;24:131-136.
Duffy SW, Chen HH, Tabár L, Fagerberg G, Paci E:
Sojourn Time, Sensitivity, and Positive Predictive Value of Mammography
Screening of Breast Cancer in Women aged 40-49.
Int. J. Epidemiol. 1996;25:1139-1145.
Larsson LG, Nyström L, Wall S, Rutqvist LE, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L:
The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality.
J. Medical Screening, 1996;3:(3), 129-132.
Nyström L, Larsson LG, Wall S, Rutqvist RE, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L:
An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
J. Medical Screening, 1996;3:(2), 85-87.
Chen HH, Duffy SW, Tabár L:
A Markov chain method to estimate the tumour progression rate from preclinical phase, sensitivity and positive predictive value for mammography in breast cancer screening.
The Statistician 1996;45:(3), 307-317.
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A.
Tumour development, histology and grade of breast cancers: prognosis and progression.
Int J Cancer. 1996 May 16;66(4):413-9 .
Tabár L:
Mammografins förmåga finna högriskfallen är nyckelfrågan. (In Swedish).
Läkartidningen 1996;93:(38), 3221.
Tabár L, Duffy SW, Chen HH:
Age-specific mortality reductions in the Swedish Two-County Trial of breast screening. Letter to Editor,
JNCI 1996;88:(1).
Day NE, Tabár L, Duffy SW, Chen HH:
Population breast-cancer screening. Letter to the Editor.
The Lancet, April 1 1995;345.
Day NE, Duffy SW, Tabár L:
Letter to the editor. Surrogate markers in cancer trials.
Statistics in Medicine 1995;14.
Duffy SW, Tabár L:
Screening for breast cancer. Letter to Editor.
The Lancet 1995;346:852.
Tabár L, Fagerberg G, Chen HH, Duffy SW, Gad A:
Tumor development, histology and grade of breast cancers: Prognosis and progression.
Int. J. Cancer 1996;66:413-419.
Tabar L.
The results of mammography must be interpreted correctly even in a debate
Lakartidningen. 1995 Aug 23;92(34):2980. Swedish.
Tabár L:
SBUs aktuella statistik inaktuell. (In Swedish).
Läkartidningen. 1995;92:(48), 4540.
Duffy SW, Chen HH, Tabár L, Day NE:
Estimation of mean sojourn time in breast cancer screening using Markov-chain model of both entry to and exit from the preclinical detectable phase.
Statistics in Medicine. 1995;14:1531-1543.
Tabár L:
Editorial
J Medical Screening. 1995;2:179.
Tabár L, Fagerberg G, Chen HH, Duffy SW, Gad A:
Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality and histology.
J. Medical Screening 1995;2:94-98.
Tabár L, Fagerberg G, Chen HH, Duffy SW, Smart C, Gad A, Smith RA:
Efficacy of Breast Cancer Screening by Age: New Results from the Swedish Two-County Trial.
Cancer 1995;75:2507-17.
Chen HH, Tabár L, Fagerberg G, Duffy SW:
Effect of breast screening after age 65.
J. Med Screening, 1995;2:10-14.
Gram I, Funkhouser E, Tabár L:
Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women.
British Journal of Cancer. 1995 No 71, 647-650.
Nyström L, Larsson LG, Rutqvist LE, Lindgren A, Lindqvist M, Rydén S, Andersson I,Bjurstam N, Fagerberg G, Frisell J, Tabár L:
Determination of cause of death among breast cancer cases in the Swedish randomised mammography screening trials. A comparison between official statistics and validation by an end point committee.
Acta Oncol, 1995;34:(2), 145-452.
Tabár L, Dean PB:
Breast cancer: A progressive, heterogeneous disease requiring multidisciplinary diagnosis and treatment.
J. Oncology Management. 1994;3(6), 12-13.
Parker S, Burbank F, Jackman R, Aucreman S, Cardenosa G, Cink T, Coscia J, Eklund GW, Evans III WO, Garver P, Gramm H, Haas D, Jacob R, Relly R, Rillebrew L, Lechner M, Perlman S, Smid A, Tabár L, Taber F, Wynn R:
Percutaneous Large-Core Breast Biopsy: A multi-institutional study.
Radiology, 1994;193:(2), 359-364.
Thurfjell E, Taube A, Tabár L:
One- versus two-view mammography screening.
Acta Radiologica 1994;35:340-344.
Duffy SW, Tabár L.
Breast cancer: have we missed the forest because of the tree?
Lancet. 1994 Oct 29;344(8931):1236.
Nyström L, Rutqvist LE, Wall S, Lindgren A, Linqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L, Larsson LG:
Breast cancer screening with mammography: overview of the Swedish randomised trials.
Lancet 1993;341:973-978.
Tabár L, Duffy SW, Warren Burhenne L:
New Swedish Breast Cancer Detection Results for Women Aged 40-49.
Cancer, 1993;72:1437-1448.
Tabár L, Fagerberg G, Day NE, Duffy SW:
The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics.
Pathol. Biol (Paris) 1992;39:(9), 846.
Tabár L, Fagerberg G, Day NE, Duffy SW, Kitchin RM:
Natural history of breast cancer: letter.
Lancet 1992;339:(8801), 1108.
Tabár L, Fagerberg G, Day NE, Duffy SW, Kitchin RM:
Breast cancer treatment and natural history: new insights from results of screening.
Lancet 1992, Febr 15;339(8790): 412-414.
Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O:
Update of the Swedish two-county program of mammographic screening for breast cancer.
Radiol Clin. North Am. 1992;30(1), 187-210.
Duffy SW, Tabár L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE:
Breast screening, prognostic factors and survival - results from the Swedish two-county study.
Br. J. Cancer 1991;64:(6), 1133-1138.
Tabar L.
The term early breast cancer is misleading
Lakartidningen. 1991 Nov 20;88(47):3996. Swedish
Tabár L, Dean PB:
Breast cancer screening; letter; comment.
Comment on: Med. J. Aust. 1991;3;154:(11), 781-782.
Tabár L, Fagerberg CJG, South MC, Day NE, Duffy SW:
The Swedish Two-County Trial of Mammographic Screening for Breast Cancer: Recent Results on Mortality and Tumour Characteristics.
Cancer Screening Eds.: AB Miller, J Chamberlain, N E Day, et al. Cambridge Univ Press UICC Public.
Tabár L, Duffy SW, Day NE:
Screening with mammography: letter.
Int. J. Technol Assess Health Care 1990;6(3), 498-500
Tabár L, Dean PB:
Calidad de la mammografia en screening.
Focus, 1990;1:39-40.
Alveryd, Andersson I, Aspegren K, Balldin G, Bjurstam N, Edström G, Fagerberg G, Glas U, Jarlman O, Larsson S, Lindbrink B, Lingaas H, Löfgren M, Rudenstam CM, Strender L, Samuelsson L, Tabár L, Taube A, Wallberg H, Åkesson P, Hallberg D:
Lightscanning versus mammography for the detection of breast cancer in screening and clinical setting.
Cancer, 1990; 65: 1671-77.
Tabár L, Fagerberg G, Duffy SW, Day NE:
WE-Projektet: mammografi minskar dödligheten i bröstcancer signifikant. (In Swedish).
Läkartidningen, 1990;87:(1-2), 36-9.
Haus A G, Feig SA, Ehrilich SM, Hendrick RE, Tabár L:
Mammography Screening: Technology, Radiation Dose and Risk, Quality Control, and Benefits to Society.
Radiology, 1990;174(3), 627-656.
Rutqvist LE, Miller AB, Andersson I, Hakama M, Hakulinen T, Sigfusson BF, Tabar L:
R educed breast-cancer mortality with mammography screening--an assessment of currently available data.
Int J Cancer Suppl. 1990;5:76-84. Review.
Tabár L:
Control of breast cancer through screening mammography.
Radiology, 1990;174:(3 Pt 1), 655-6.
Tabár L, Dean PB:
Playing the right cards in preoperative breast workup.
Diagnostic Imaging Intl., Oct 1989, 85-89.
Tabár L, Dean PB:
Optimum Mammography Technique.
Administrative Radiology, May 1989; pp 54-56.
Tabár L:
Principi basilari della diagnosis mammografica. (In Italian)
In: Límging senologico metodiche e scelte. Eds. Luzzatti, G., Tonegoutti, M., 1989;pp 99-112.
Bergkvist L, Tabár L, Adami HO, Persson I, Bergström R:
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment.
American Journal of Epidemiology, 1989;130:(3), 503-510.
Tabár L:
The role of Mammographic Screening in the Control of Breast Cancer: An Overview.
In: High-Risk Breast Cancer. Eds. Ragaz/Ariel, Springer Verlag Berlin. Heidelberg 1989, pp 253-261.
Tabár L:
Breast. Editorial overview.
Current Opinion in Radiology 1989,1:187.
Tabár L , Fagerberg G, Duffy SW, Day NE.
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
J Epidemiol Community Health. 1989 Jun;43(2):107-14.
Tabár L, Haus AG:
Processing of mammographic films: technical and clinical considerations.
Radiology, 1989;173:(1), 65-69.
Tabar L, Duffy SW.
Malmo mammographic screening trial.
BMJ. 1989 Jan 7;298(6665):48-9.
Tabár L, Dean PB:
The value of mammography screening in women under age 50 years.
Invest. Radiol. 1989;24:(5), 420-4.
Tabár L, Dean PB:
The present state of screening for breast cancer.
Seminars of Surgical Oncology, 1989;5:(2), 94-101.
Tabár L, Fagerberg G, Day NE:
The results of periodic one-view mammography screening in randomized, controlled trial in Sweden. Part II. Evaluation of the results.
In: Screening for Breast Cancer. Eds. Day, N. E., Miller, A. B. H. Huber Publishers, 1988 UICC, pp 39-44.
Fagerberg G, Tabár L:
The results of periodic one-view mammography screening in a randomized, controlled trial in Sweden. Part. I. Background, organization, screening programme and tumor findings.
In: Screening for Breast Cancer, Eds. Day, N. E. & Miller, A. B. H. Huber Pulishers 1988, UICC, pp 33-38.
Day NE, Walter S, Tabár, et al:
The sensitivity and lead time of breast cancer screening.
In: Screening for Breast Cancer. Eds. Day, N. E., Miller, A. B. H. Huber Publishers. UICC 1988, pp 39-44.
Tabar L, Fagerberg G:
Låg sensitivitet, felräknad statistik styrka - två av flera svaga punkter i Malmö-studien. (In Swedish).
Läkartidningen, 1988;85:(47), 4055-4056.
Bergkvist L, Tabar L, Bergstrom R, Adami HO:
Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program.
Am J Epidemiol. 1987 Dec;126(6):1075-81.
Tabár L, Dean PB:
The control of breast cancer through mammography screening. What is the evidence?
Radiologic Clinics of North America, Sept. 1987;25:(5), 993-1005.
Tabár L, Duffy SW, Krusemo UB:
Detection method, tumor size and node metastases in breast cancers diagnosed during a trial of breast cancer screening.
Eur. J. Cancer Clin. Oncol., 1987;23:(7), 959-962.
Tabár L, Fagerberg G, Day NE, Holmberg L:
What is the optimum interval between mammographic screening examinations? - An analysis on the latest results of the Swedish two-county breast cancer screening trial.
Br. J. Cancer, 1987;55, 547-551.
Tabár L:
Screening for breast cancer: an Overview.
In: Recent Results in Cancer Research. Ed: S. Brunner. Springer Verlag. 1987;105:58-61.
Duffy SW, Tabár L:
Letter to the Editors. Screening for Breast Cancer.
J Chron Dis. 1987;40:(9), 907-908.
Tabár L:
Mammography in Population Screening: An Overview.
Administrative Radiology, November 1986 pp 32-34.
Holmberg L, Adami HO, Lundstrom T, Persson I, Tabar L.
Mass screening mammography results in an increased need for surgical wards.
Lakartidningen. 1986 May 28;83(22):2047-9. Swedish.
Holmberg L, Tabár L, Adami HO, Bergström R:
Survival in breast cancer diagnosed between mammographic screening examinations.
Lancet, 1986; II: 27.
Holmberg L, Adami HO, Persson I, Lundström T, Tabár L:
Demands on surgical in patient services after mass mammographic screening.
Brit. Med. Journal. 1986;293:779-781.
Tabár L, Gad A, Holmberg LH, Ljungquist U, Fagerberg G, Baldetorp L, Grötoft O, Lundström B, Månson JC:
Minskad mortalitet i bröstcancer gonom hälsokontroll med mammografi. (In Swedish).
Nordisk Medicin 1985;100:6-7.
Tabár L, Dean PB:
Basic principles of mammographic diagnosis.
Diagn. Imag. clin. Med. 1985;54:146-457.
Tabár L, Fagerberg G, Gad A, et al:
Reduction in mortality from breast cancer after mass screening with mammography.
Lancet, 1985;I:829-832.
Tabár L, Gad A, Holmberg L, Ljungquist U:
Significant reduction in advanced breast cancer.
Diagn. Imag. clin. Med. 1985;54:158-164
Tabár L, Dean PB, Makela P, Virtama P:
Magnification immersion radiography of the distal extremities.
Applied Radiology, 1984.
Tabár L, Dean PB:
Quality aspects in mammography.
Medicamundi. 1984;29:(2), 71-75.
Tabár L, Dean PB:
Risks and benefits of mammography in population screening for breast cancer
In: Breast Cancer: Diagnosis and management. Ed.: G. Bonadonna. 1984; Chapter 5, pp 63-74. John Wiley & Sons Ltd.
Tabár L:
Microfocal spot magnification mammography.
In: Recent results in Cancer Research. Ed: S. Brunner. Springer Verlag, 1984;90:62-67.
Tabár L, Åkerlund E, Gad A:
Five-year experience with single-view mammography. Randomized controlled screening in Sweden.
In: Recent results in Cancer Research. Ed: S. Brunner. Springer Verlag. 1984;90:105-113.
Tabár L, Dean PB, Péntek Z:
Galactography: The Diagnostic Procedure of Choice for Nipple Discharge.
Radiology, 1983;14:31-38.
Holmberg L, Tabár L, Gad A:
Treatment of breast cancer detected on screening in Sweden.
In: Breast Cancer: Current Diagnosis and Treatment. Eds: S. A. Feig and R. McLelland. Masson Publishing USA Inc. 1983; Chapter 64.
Andersson I, Hellstrom L, Bjurstam N, Lundgren B, Fagerberg G, Tabar L.
Breast cancer screening by mammography in Sweden]
Laka rtidningen. 1983 Jun 22;80(25):2559-62. In Swedish.
Tabár L, Dean PB:
THEACHING ATLAS OF MAMMOGRAPHY.
Thieme Verlag Stuttgart. 1983.
LEHRATLAS DER MAMMOGRAPHIE. (German Edition).
ATLAS DE MAMMOGRAFIA. 1985. (Spanish and Portugees Edition).
ATLANTE DIAGNOSTICO DI MAMMOGRAFIA. 1987. (Italian Edition).
Tabár L, Gad A, Åkerlund E, Holmberg L:
Screening for breast cancer in Sweden. Chapter 28.
In: Breast Carcinoma. Current Diagnosis and Treatment. Eds. S. A. Feig, R. McLelland. Masson Publishing , New York, 1983, pp 315-326.
Tabár L, Dean PB:
Screen/film mammography: Quality control. Chapter 13.
In: Breast Carcinoma. Current Diagnosis and Treatment. Eds. S. A. Feig, R. McLelland. Masson Publishing, New York, 1983. pp 161-167.
143. Tabár L, Dean PB:
Magnification immersion radiography: better soft tissue visualization in the hands.
Fortschr. Röntgenstr., 1982;136:444-447.
Tabár L, Dean PB:
Mammographic parenchymal patterns: risk indicator for breast cancer?
J. Amer. Med. Assoc., 1982;247:(2), 185-189.
Tabár L, Dean PB:
Mondor´s disease: clinical, mammographic and pathologic features.
Breast, Diseases of the Breast. 1981;7:(1), 18-20.
Tabár L, Péntek Z, Dean PB:
The diagnostic and therapeutic value of breast cyst puncture and pneumocystography.
Radiology, 1981;141:659-66 3.
Tabár L, Gad A:
Screening for breast cancer: the Swedish Trial.
Radiology 1981;138:(1), 219-222.
Andersson I, Fagerberg G, Lundgren B, Tabár L:
Breast cancer screening in Sweden. The single modality approach.
Radiologe, 1980;20:608-611.
Gad A, Tabár L:
Minimal breast cancer. A correlative mammographic and histopathologic study.
In: Early detection of breast cancer (Tidig upptäckt av bröstcancer, in Swedish). Stockholm, 1979; pp 89.
Tabár L, Gad A, Åkerlund E, Fors B, Fagerberg G, Baldetorp L, Gröntoft O, Lamke LO:
Screening for breast cancer in Sweden: A randomized, controlled trial.
In: Reduced dose mammography. Eds. Logan, W.W., Muntz, E. Ph. Masson Publishing USA Inc., 1979; pp 407.
Tabár L, Gad A, Åkerlund E, Fors B:
Randomized breast cancer screening trial in Kopparberg county.
In: Early detection of breast cancer. (Tidig upptäckt av bröstcancer, in Swedish). Stockholm, 1979; pp 89.
Tabár L, Dean PB:
Interventional radiologic procedures in the investigation of lesions of the breast.
In: Radiologic Clinics of North America. 1979;XVII:(3), 607-621.
Pèntek Z, Bakó B, Szentgáli G, Tabár L, Balogh J, Szarka J:
Mammographic screening for breast cancer in a rural population preselected via physical examination and epidemiologic questionnaire.
Röntgenblätter, 1978;31:173.
Tabár L, Kett K, Nèmeth A:
Tuberculosis of the Breast.
Radiology, 1976;118:587-589.
Tabár L, Pèntek Z:
Pneumocystography of benign and malignant intracystic growths of the female breast.
Acta Radiol. Diagn., 1976;17:(6), 829-837.
Tabár L:
The role of complex radiologic examination methods in the diagnosis of occult breast cancers. (In Hungarian).
Hungarian Radiology, 1975;27:193.
Somogyi J, Tabár L, Böhm K:
Stenosis of the coeliac trunk (coeliac artery) due to external compression. (In Hungarian).
Hungarian Radiology, 1975;27:193-202.
Tabár L, Pèntek Z:
Das Fibro-adeno-lipom der Mamma. (In German).
Radiologe, 1975;15:77-79.
Horváth T, Nagy I, Keszthelyi B, Schmelzer M, Tabár L:
Blood clotting disturbances in angioplastic diseases (In Hungarian).
Hungarian Archives of Medicine, 1974;27:86-94.
Kuhn E, Tabár L, Horváth L, Stefanits K, Than Z:
Radiological diagnosis of malignant lymphoma of the gastrointestinal tract. (In Hungarian).
Hungarian Radiology, 1974;26:281-292.
Tabár L, Somogyi J, Böhm K:
Pneumoperikardium traumatischen Ursprungs. (In German).
Fortschr Röntgenstr, 1974;121:698-701.
Tabár L, Màrton Z, Kàdas I:
Galactography in the examination of secretory breasts.
American J Surg, 1974;127:282-286.
Somogyi J, Tabár L, Böhm K:
Die Bedeutung der Auskultation der Abdominalen unpaarigen Visceralarterien. (In German).
Munchener Medizinische Wochenschrift. 1974;115(17):979-83.
Tabár L, Màrton Z, Kàdas I:
Die Pneumocystographie der Brust. (In German).
Chirurg, 1973;44(9):428-431.
Tabár L, Kàdas I, Marton Z, Nèmeth A, Kosaras B:
The significance of mammography, galactography and pneumocystography in detecting occult carcinomas of the breast.
Surgery Gynecology and Obst., 1973;137(6):965-970.
Somogyi J, Tabár L:
Stenoses of the great, unpaired branches of the abdominal aorta. (in Hungarian).
Hungarian Radiology, 1973;25:200-204.
Tabàr L, Màrton Z, Kàdas I:
Verkalkungen im männlichen Brustkrebs. (In German).
Fortschr. Röntgenstr., 1972;117(3):360-362.
Tabar L, Herr G, Hàber J:
Congenital absence of the left part of the pericardium. (In Hungarian)
Orv Hetil. 1972 Apr 9;113(5):879-81.
Kett K, Kàdas I, Tabár L, Lukács L:
The possible role of dermal lymphatics in the dissemination of breast cancer.
Lymphology, 1972;5(1):37-41.
Tabár L, Herr G, Hàber J:
Kongenitale Aplasie der linken Perikardhälfte. (In German).
Fortschr. Röntgenstr., 1972;116(1), 32-35.
Benkö Gy, Háber G, Than Z, Kishindi Kiss K, Varga Gy, Tabár L:
Die Untersuchung der Lungzirkulation bei Silikosen durch Segmentangiographie. (In German).
Fortschr. Röntgenstr. 1971;114(2), 207-214.
|